Description
Although germline variation testing is traditionally performed using DNA obtained from blood or other liquid samples, determining somatic variation in cancer samples requires DNA extraction directly from tissues. Additionally, epigenetic markers, such as 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) are tissue-specific and change in selected disease states. However, several substances present in tissues are known to inhibit downstream reactions, including polymerase chain reaction PCR). For this project, we are assessing the quantity and quality of DNA obtained from extractions of various vital organs using 30 different commercially available DNA extraction kits to determine optimal kits for each tissue.
Recommended Citation
Powers, Ryan; Schultz, Noah R.; Burger, Brandon J.; Dougherty, John Jr.; Obilor, Ezenna; Ruiz, Alexander; Frey, Corwin; Hill, Nathaniel; Laughrey, Lara; Brain, Patrick Tanner; McMahon, Sara; Feltner, Parker; Tung, Steven; Sajady, Daoud; Jenkins, Elden; Jarquin, julian; Baker, Serin; Andrews, Aaron; Kriak, John A.; Bills, Kyle B.; and Sant, David W., "DNA Extraction Method Development for Solid Tissues" (2024). Annual Research Symposium. 44.
https://ecommons.roseman.edu/researchsymposium/2024/basic_sciences/44